Intelligent Bio Solutions Stock Price, News & Analysis (NASDAQ:INBS) $0.28 -0.03 (-10.37%) (As of 12:04 PM ET) Add Compare Share Share Today's Range$0.27▼$0.3050-Day Range$0.21▼$1.3452-Week Range$0.20▼$32.00Volume669,767 shsAverage Volume1.74 million shsMarket Capitalization$2.40 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Intelligent Bio Solutions MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestBearish8.47% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.92Based on 2 Articles This WeekInsider TradingAcquiring Shares$192 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($1.67) to ($0.47) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.76 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Intelligent Bio Solutions. Previous Next 2.0 Short Interest Percentage of Shares Shorted8.47% of the float of Intelligent Bio Solutions has been sold short.Short Interest Ratio / Days to CoverIntelligent Bio Solutions has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Intelligent Bio Solutions has recently increased by 5.11%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldIntelligent Bio Solutions does not currently pay a dividend.Dividend GrowthIntelligent Bio Solutions does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for INBS. Previous Next 4.4 News and Social Media Coverage News SentimentIntelligent Bio Solutions has a news sentiment score of 1.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.82 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Intelligent Bio Solutions this week, compared to 1 article on an average week.Search Interest15 people have searched for INBS on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.MarketBeat Follows11 people have added Intelligent Bio Solutions to their MarketBeat watchlist in the last 30 days. This is an increase of 450% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Intelligent Bio Solutions insiders have bought more of their company's stock than they have sold. Specifically, they have bought $192.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 0.28% of the stock of Intelligent Bio Solutions is held by insiders.Percentage Held by InstitutionsOnly 9.28% of the stock of Intelligent Bio Solutions is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($1.67) to ($0.47) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Intelligent Bio Solutions is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Intelligent Bio Solutions is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIntelligent Bio Solutions has a P/B Ratio of 0.17. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Intelligent Bio Solutions Stock (NASDAQ:INBS)Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Read More INBS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INBS Stock News HeadlinesNovember 27, 2023 | finance.yahoo.comAustralian Civil Construction Entity, State Road Constructions, Selects Intelligent Fingerprinting Drug Screening System as Workplace Drug Screening SolutionNovember 19, 2023 | uk.finance.yahoo.comIntelligent Bio Solutions Inc. (INBS)November 28, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 18, 2023 | americanbankingnews.comFY2024 EPS Estimates for Intelligent Bio Solutions Inc. (NASDAQ:INBS) Lifted by Zacks Small CapNovember 15, 2023 | finance.yahoo.comINBS: New Zealand & American ExpansionNovember 11, 2023 | finance.yahoo.comIntelligent Bio Solutions First Quarter 2024 Earnings: Misses ExpectationsNovember 9, 2023 | msn.comWhat's Going On With Intelligent Bio Solutions Stock?November 8, 2023 | finance.yahoo.comIntelligent Bio Solutions Inc. Reports Fiscal 2024 First Quarter Financial Results and Operational HighlightsNovember 28, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comOctober 24, 2023 | tmcnet.comIntelligent Bio Solutions' Innovative Drug Screening Technology Now Offered in New ZealandOctober 24, 2023 | finance.yahoo.comIntelligent Bio Solutions’ Innovative Drug Screening Technology Now Offered in New ZealandOctober 5, 2023 | finance.yahoo.comIntelligent Bio Solutions Adds Logistics Firm to Fingerprint Drug Screening Portfolio and Completes Major Milestone with Existing ClientOctober 4, 2023 | finance.yahoo.comIntelligent Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters’ Overallotment OptionOctober 4, 2023 | seekingalpha.comIntelligent Bio Solutions announces pricing of $4M underwritten public offeringOctober 2, 2023 | marketwatch.comIntelligent Bio Solutions Shares Slide Premarket on Equity OfferingOctober 2, 2023 | msn.comWhy Is Intelligent Bio Solutions (INBS) Stock Down 52% Today?October 2, 2023 | finance.yahoo.comIntelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public OfferingSeptember 27, 2023 | finance.yahoo.comIntelligent Bio Solutions Obtains ISO Recertification for its Intelligent Fingerprinting Drug Screening BusinessSeptember 27, 2023 | finance.yahoo.comIntelligent Bio Solutions Obtains ISO Recertification for its Intelligent Fingerprinting Drug Screening BusinessSeptember 21, 2023 | finance.yahoo.comIntelligent Bio Solutions Successfully Debuts Intelligent Fingerprinting Drug Screening Solution at the 2023 Workplace Health & Safety Show in Sydney, AustraliaSeptember 8, 2023 | finance.yahoo.comIntelligent Bio Solutions Completes Critical Development Milestone in Plans to Add Ketamine and Tramadol to Fingerprint Drug TestSeptember 5, 2023 | finance.yahoo.comINBS: Australia Off to a Strong StartAugust 25, 2023 | benzinga.comIntelligent Bio Solutions (NASDAQ: INBS) Launches Global Expansion of Its Cutting-Edge Intelligent Drug Screening SystemAugust 1, 2023 | finance.yahoo.comIntelligent Bio Solutions Secures 8 New Customers with a Combined Workforce of Over 10,000 Employees Two Months into Product Launch in AustraliaAugust 1, 2023 | finance.yahoo.comIntelligent Bio Solutions Secures 8 New Customers with a Combined Workforce of Over 10,000 Employees Two Months into Product Launch in AustraliaJuly 25, 2023 | finance.yahoo.comIntelligent Bio Solutions Inc.'s (NASDAQ:INBS) Profit OutlookJuly 11, 2023 | ecampusnews.comLeveraging AI to Power Today’s Intelligent CampusSee More Headlines Receive INBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/08/2023Today11/28/2023Next Earnings (Estimated)2/13/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:INBS CUSIPN/A CIK1725430 Webgbs.inc Phone646-828-8258FaxN/AEmployees51Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($9.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,630,000.00 Net Margins-510.29% Pretax Margin-511.76% Return on Equity-147.23% Return on Assets-64.92% Debt Debt-to-Equity Ratio0.25 Current Ratio0.39 Quick Ratio0.25 Sales & Book Value Annual Sales$1.26 million Price / Sales2.13 Cash FlowN/A Price / Cash FlowN/A Book Value$1.58 per share Price / Book0.19Miscellaneous Outstanding Shares8,730,000Free Float8,710,000Market Cap$2.68 million OptionableNot Optionable Beta4.03 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Harry Simeonidis (Age 56)President & CEO Comp: $310.79kMr. Spiro Kevin Sakiris B.Bus (Age 61)C.A., CA, Dip Law, Chief Financial Officer Comp: $274.43kMs. Victoria Gavrilenko (Age 40)Operations Manager Comp: $45kMr. Alex ArzenoVP of Investor RelationsKey CompetitorsReShape LifesciencesNASDAQ:RSLSBIOLASENASDAQ:BIOLAcutus MedicalNASDAQ:AFIBBrickell BiotechNASDAQ:BBIAptevo TherapeuticsNASDAQ:APVOView All CompetitorsInsidersHarry SimeonidisBought 100 shares on 8/31/2023Total: $192.00 ($1.92/share)View All Insider Transactions INBS Stock Analysis - Frequently Asked Questions How have INBS shares performed in 2023? Intelligent Bio Solutions' stock was trading at $3.9980 at the start of the year. Since then, INBS stock has decreased by 93.1% and is now trading at $0.2750. View the best growth stocks for 2023 here. When is Intelligent Bio Solutions' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024. View our INBS earnings forecast. How were Intelligent Bio Solutions' earnings last quarter? Intelligent Bio Solutions Inc. (NASDAQ:INBS) released its quarterly earnings data on Wednesday, November, 8th. The company reported ($1.04) EPS for the quarter. The business earned $0.80 million during the quarter. Intelligent Bio Solutions had a negative trailing twelve-month return on equity of 147.23% and a negative net margin of 510.29%. When did Intelligent Bio Solutions' stock split? Intelligent Bio Solutions's stock reverse split on Friday, February 10th 2023. The 1-20 reverse split was announced on Friday, February 10th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of Intelligent Bio Solutions? Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:INBS) was last updated on 11/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intelligent Bio Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.